Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
Year: 1994
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
DOI: 10.1007/bf00873232
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2084562398
